At AltraBio, we specialize in the research and development of advanced solutions for analyzing and interpreting biomedical data across preclinical and clinical stages. Our mission is to create cutting-edge analytical and predictive tools for complex datasets, including omics data (genomics, transcriptomics, proteomics) and cytometry data (conventional, mass, spectral).

Our Key Activities:
- Omics: We harness the potential of genomics, transcriptomics, and proteomics to uncover valuable insights from these complex datasets.
- Cytometry: Auto-gating, biomarker discovery, QC, and data visualization, allowing for comprehensive and in-depth data interpretation.

Proprietary Tools: One of our most significant achievements is the development of a proprietary tool that automates cytometry file processing. Utilizing machine learning, our tool replicates predefined gating strategies across large sample sets, streamlining study processes and significantly reducing time and costs. This innovation enhances the robustness and reliability of results and has been widely validated through numerous clinical studies, successfully processing thousands of files.

Why Choose AltraBio?
- Cutting-Edge Technology: We stay at the forefront of technology to deliver the most advanced analytical solutions.
- Proven Success: Our methods and tools have been rigorously tested and proven effective in clinical settings.
- Efficiency and Cost-Effective: We aim to optimize study processes, making them more efficient and reliable.

Contact us to discover how AltraBio can enhance your research and development efforts.